/ Not yet recruitingNot Applicable A Double Blind, Placebo Controlled, Pivotal Phase III Study Evaluating Xilonix™ in Symptomatic Colorectal Cancer Patients Refractory To Standard Therapy
100 Clinical Results associated with XBiotech Germany GmbH
0 Patents (Medical) associated with XBiotech Germany GmbH
100 Deals associated with XBiotech Germany GmbH
100 Translational Medicine associated with XBiotech Germany GmbH